Pain Medicine ConsultantsMedical Anesthesia Consultants 1601 Ygnacio Vly Rd, Walnut Creek, CA 94598 925 543-0140 (phone)
Pain Medicine ConsultantsMedical Anesthesia Consultants 5924 Stoneridge Dr STE 102, Pleasanton, CA 94588 925 543-0140 (phone)
Education:
Medical School University of Michigan Medical School Graduated: 2008
Languages:
English
Description:
Dr. Tran graduated from the University of Michigan Medical School in 2008. He works in Walnut Creek, CA and 1 other location and specializes in Anesthesiology. Dr. Tran is affiliated with John Muir Medical Center Walnut Creek and San Ramon Regional Medical Center.
Systems and methods are presented for measuring power levels of primary and interfering signals as well as noise, particularly for satellite transmitted signals. A typical method comprises the steps of receiving a signal comprising a primary signal, an interference signal and noise, demodulating the primary signal to remove a carrier frequency, decoding the primary signal to obtain symbols, estimating a power level of the primary signal based upon the demodulated and decoded primary signal. Additionally, an ideal primary signal can be generated from the carrier power and frequency and the symbols and subtracted from the received signal to produce the noise and interference signal. The noise and interference power is then estimated from the noise and interference signal.
Composition And Method For Stabilization And Delivery Of Therapeutic Molecules
A composition and treatment method are disclosed for one or more of alpha, beta, and gamma-Cyclodextrin and a natural molecule or fragment thereof wherein the natural molecule is sometimes Glutathione, is non-acetylated, non-Esterified, and non-fatty acid attached, and the composition is administered parenterally and non-interveneously.
Chinh N. Tran - Garden Grove CA Adrian C. Maldonado - Chula Vista CA Ratnasamy Somanathan - San Diego CA
Assignee:
Allied-Signal Inc. - Morris Township, Morris County NJ
International Classification:
B01D 6100
US Classification:
210654
Abstract:
A thin-film seimpermeable composite membrane employs the reaction product of N-alkyl phenylenediamine or N,N'-dialkyl phenylenediamine and a poly acyl halide, such as trimesoyl chloride. Preferably the membrane is post-treated with an acid solution followed by an aqueous solution of polyvinyl alcohol and a buffer and/or base to improve its physical properties.
Chinh N. Tran - Garden Grove CA Adrian C. Maldonado - Chula Vista CA Ratnasamy Somanathan - San Diego CA
Assignee:
Fluid Systems Corporation - San Diego CA
International Classification:
B05D 300
US Classification:
427333
Abstract:
A thin-film seimpermeable composite membrane employs the reaction product of N-alkyl phenylenediamine or N,N'-dialkyl phenylenediamine and a poly acyl halide, such as trimesoyl chloride. Preferably the membrane is post-treated with an acid solution followed by an aqueous solution of polyvinyl alcohol and a buffer and/or base to improve its physical properties.
Method For Stabilization And Delivery Of Therapeutic Molecules
A method of treatment is disclosed, comprising administering a composition of Cyclodextrin and reduced, nanonized L-Glutathione to a patient in need of treatment, wherein the L-Glutathione molecule is non-acetylated, non-Esterified, and non-fatty acid attached.
Method For Stabilization And Delivery Of Therapeutic Molecules
A method of treatment is disclosed, comprising administering a composition of Cyclodextrin and reduced, nanonized L-Glutathione to a patient in need of treatment, wherein the L-Glutathione molecule is non-acetylated, non-Esterified, and non-fatty acid attached.
Method For Stabilization And Delivery Of Therapeutic Molecules
A method of treatment is disclosed, comprising administering a composition of Cyclodextrin and reduced, nanonized L-Glutathione to a patient in need of treatment, wherein the L-Glutathione molecule is non-acetylated, non-Esterified, and non-fatty acid attached.
Method For Stabilization And Delivery Of Therapeutic Molecules
A method of treatment is disclosed, comprising administering a composition of Cyclodextrin and one or more of a natural molecule or fragment thereof in at least one carrier to a patient in need of treatment, wherein the natural molecule is non-acetylated, non-Esterified, and non-fatty acid attached.